Analyst Recommendations Review: Endo International plc (ENDP)

Taking a brief view of stock performance, we see that Endo International plc (NASDAQ:ENDP) shares are now trading $-1.512 off the 50-day moving average of $12.137 and $-5.766 off of the 200-day moving average of $16.391. The number of analysts agreeing with this consensus is 15. Zacks Investment Research lowered Endo International plc - from a "hold" rating to a "sell" rating in a research note on Tuesday, January 3rd. The analysts offering Earnings Estimates for the company were believing that Endo International plc (ENDP) could bring EPS of $1.63/share. On average, equities analysts predict that Endo International plc - will post $3.60 EPS for the current year.

Canaccord Genuity Initiates Coverage On Endo International plc (ENDP)'s stock to Hold with no specific Price Target.

In the liquidity ratio analysis; quick ratio for most recent quarter was 0.80 while current ratio for time period was 1.00. Here, 1 indicates a Strong Buy and 5 indicates a Strong Sell.

ENDP stock's price is now -69.55% down from its 52-week high and +9.57% up from its 52-week low.

Endo International plc - (NASDAQ:ENDP) opened at 10.76 on Wednesday.

The stock's price switched up -10.27% 20-Days Simple Moving Average, dropped -15.51% from 50-Days Simple Moving Average and fell -36.66% from 200 Days Simple Moving Average. The company's market cap is $2.4 Billion.

Endo International plc (ENDP) reported its last quarter results on 02/28/2017. By placing estimates on the earnings of a firm for certain periods (quarterly, annually, etc), analysts can then use cashflow analysis to approximate a fair value for a company, which in turn will give a target share price for publicly traded companies. Barings LLC increased its stake in shares of Endo International plc - by 11.2% in the fourth quarter. The firm earned $1.24 billion during the quarter, compared to analysts' expectations of $1.17 billion. While the actual EPS the company reported in the same quarter previous year was 1.08/share. The Monthly and Yearly performances are -21.17 percent and -64.17 percent respectively. Based on the filings, last years Annual Earnings was, $4.73. The company's last traded volume of 12.6 million shares as compared to it's an average volume of 8.65 million shares. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. The Insider Ownership of the company now is 0.2 percent, and Institutional Ownership is 99.9 percent.

Several large investors have recently added to or reduced their stakes in the company. Finally, Mitsubishi UFJ Trust & Banking Corp raised its stake in shares of Endo International plc - by 1.1% in the third quarter. Icon Advisers Inc. Co. raised its stake in shares of Endo International plc - by 28.6% in the third quarter. Earlier the firm had a rating of Buy on the company shares.

In related news, Director Nancy J. Hutson sold 5,325 shares of the stock in a transaction that occurred on Thursday, March 9th. Company price to earnings (P/E) ratio, which measures the relationship between the earnings of a company and its stock price, is calculated as 26.45. California State Teachers Retirement System raised its stake in shares of Endo International plc - by 0.9% in the third quarter. Mitsubishi UFJ Trust & Banking Corp now owns 425,759 shares of the company's stock valued at $8,579,000 after buying an additional 4,544 shares during the period.

Endo International PLC, formerly Endo Health Solutions Inc is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services.